Gwynneth D. Offner, PhD
Associate Professor, Medicine
Biography
Gwynneth D. Offner, Ph.D. is the Director of the M.S. in Medical Sciences Program, an Associate Professor in the Department of Medicine and an Assistant Dean for Admissions at BUSM. While her primary focus is teaching, advising and mentoring students, Dr. Offner also directed an NIH-funded research program for over 25 years. She is currently a member of the leadership team for PRiSM, an integrated course for first year medical students and the director of the PRiSM GI and Nutrition module. She also teaches in and directs the Biochemistry course for M.S. in Medical Sciences students. Her research interests include curriculum development and assessment.
Other Positions
- Assistant Dean, Admissions, Boston University Chobanian & Avedisian School of Medicine
- Research Assistant Professor, Biochemistry & Cell Biology, Boston University Chobanian & Avedisian School of Medicine
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
- Boston Medical Center
Websites
Education
- Boston University, PhD
- Wellesley College, BA
Publications
- Published on 4/28/2016
Gallan AJ, Offner GD, Symes K. Vertical integration of biochemistry and clinical medicine using a near-peer learning model. Biochem Mol Biol Educ. 2016 Nov 12; 44(6):507-516. PMID: 27123831.
Read at: PubMed - Published on 12/12/2012
Oppenheim FG, Helmerhorst EJ, Lendenmann U, Offner GD. Anti-candidal activity of genetically engineered histatin variants with multiple functional domains. PLoS One. 2012; 7(12):e51479. PMID: 23251551.
Read at: PubMed - Published on 5/3/2011
Soares RV, Offner GD, Assis MA, Silva KC, Zenóbio EG. An unusual glycoform of human salivary mucin MG2. Clin Oral Investig. 2012 Jun; 16(3):761-6. PMID: 21538073.
Read at: PubMed - Published on 12/6/2010
Komatsu T, Salih E, Helmerhorst EJ, Offner GD, Oppenheim FG. Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry. J Proteome Res. 2011 Feb 4; 10(2):646-55. PMID: 21080726.
Read at: PubMed - Published on 2/23/2010
Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR, Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010 Jun; 105(6):1346-53. PMID: 20179698.
Read at: PubMed - Published on 12/15/2005
Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005 Dec 15; 40(5):538-44. PMID: 16284529.
Read at: PubMed - Published on 11/15/2005
Chen ZY, Wang X, Zhou Y, Offner G, Tseng CC. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res. 2005 Nov 15; 65(22):10394-400. PMID: 16288030.
Read at: PubMed - Published on 9/16/2005
Bruno LS, Li X, Wang L, Soares RV, Siqueira CC, Oppenheim FG, Troxler RF, Offner GD. Two-hybrid analysis of human salivary mucin MUC7 interactions. Biochim Biophys Acta. 2005 Oct 30; 1746(1):65-72. PMID: 16203048.
Read at: PubMed - Published on 9/13/2005
Li X, Wang L, Nunes DP, Troxler RF, Offner GD. Suppression of MUC1 synthesis downregulates expression of the epidermal growth factor receptor. Cancer Biol Ther. 2005 Sep; 4(9):968-73. PMID: 16082192.
Read at: PubMed - Published on 5/1/2004
Soares RV, Lin T, Siqueira CC, Bruno LS, Li X, Oppenheim FG, Offner G, Troxler RF. Salivary micelles: identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch Oral Biol. 2004 May; 49(5):337-43. PMID: 15041480.
Read at: PubMed
View 62 more publications: View full profile at BUMC